Skip to content

Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Change in the Resistance Profile of Escherichia Coli in Infections of Community Origin: The Importance of Antimicrobial Stewardship

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06305455
Enrollment
200
Registered
2024-03-12
Start date
2024-04-30
Completion date
2024-10-31
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial Resistance

Keywords

antimicrobial resistance, Escherichia coli ESBL, antimicrobial stewardship, community infections

Brief summary

The main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community - defined as those with cultures collected within 48 hours of hospital admission - and admitted to the intensive care unit.

Detailed description

Background: The growing antimicrobial resistance in bacterial pathogens represents a severe public health problem. Isolation of Escherichia coli ESBL has been identified more frequently over the years due to the worldwide dissemination of strains with this phenotypic profile. The ICU has a fully functioning Antimicrobial Stewardship team, with data managed daily. Thus, the investigators identified increasing E. coli ESBL isolates resistant to standard empiric antimicrobial therapy in community-based severe infections. Purpose: The choice of empirical antimicrobial therapy is an increasingly present challenge in clinical practice, often determining the outcome of critically ill patients. As this is a highly relevant topic in managing this patient profile, antimicrobial stewardship protocols are essential in health services, enabling continuous community monitoring of emerging resistance profiles. The justification for this study is based on the possibility of adding knowledge on the topic, aiming to add to the global theoretical collection and alert about the locoregional occurrence of changes in the bacterial resistance profile. Objectives: The main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community - defined as those with cultures collected within 48 hours of hospital admission - and admitted to the ICU.

Interventions

BIOLOGICALEscherichia coli ESBL

To evaluate the change in the resistance profile of infections of community origin caused by Escherichia coli, isolated from any culture material in patients admitted to the intensive care unit of a tertiary hospital.

Sponsors

José Raimundo Araujo de Azevedo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All 18 years and old patients admitted to the ICU * Positive cultures for E. coli * Any sample collected within 48 hours of hospital admission

Exclusion criteria

* Lack of necessary data

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Escherichia coli resistance24 monthsThe main objective of the study is to describe the antimicrobial resistance profile of E. coli isolated in patients from the community admitted to the ICU.

Contacts

Primary ContactRODRIGO AZEVEDO, MD, PhD
rpdeazevedo@gmail.com+55 98 991920321
Backup ContactVITORIA OLIVEIRA, MD
vitoriagoncaalves@gmail.com+55 98 32168110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026